Akita-Based UMN Pharma To Invest ¥2 billion In New Vaccine Production Facility
This article was originally published in PharmAsia News
Executive Summary
Japanese biopharmaceutical venture company UMN Pharma announced plans to invest ¥2 billion to build a new factory in Akita New Town Industrial Park. The construction starts this October and is estimated to be completed in October 2010. Akita prefecture will invest ¥9.5 million from its Akita Academy Venture Fund. UMN has been received local government funding since its start in 2004. (Click here for more - Japanese language